About

Peyton Thompson, MD, MSCR is a physician scientist specializing in the field of Pediatric Infectious Diseases.

Dr. Thompson advocates for health equity and the inclusion of a birth-dose vaccine of hepatitis B in DRC and throughout sub-Saharan Africa. She is also passionate about mentoring trainees, ranging from medical students to residents/fellows to PhD students. Her research interests focus broadly on the promotion of infant health in low-resource areas through vaccination, with a particular interest in hepatitis B. She leads a team of DRC- and US-based researchers in studies on the prevention of vertical transmission of hepatitis B virus, for which she has funding and support from the Doris Duke Foundation, the NIH, Abbott Laboratories and Gilead Sciences.

Through Dr. Thompson’s research as a clinician scientist, she has advocated for improving maternal and infant health through quality preventive measures against HBV and other vaccine-preventable infectious diseases. Her work with colleagues in the Democratic Republic of Congo (DRC) on HBV prevention has informed policy at the national level and has led to the country’s commitment to implement universal HBV birth dose administration in the near future towards HBV elimination in the DRC.